ArticleFrontiers in oncology2020

One-Year Outcome of Multiple Blood-Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma.

So Hee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.